Wall Street likes the company's promising pipeline ... this weight-loss drug stock could more than 3x over the next 12 ...
Walgreens jumps as Sycamore agrees to $11.45 a share purchase Sycamore Partners agreed to acquire Walgreens Boots (WBA) in a ...
Novo Nordisk has asked the FDA to stop compounding ... The request follows a similar move by Eli Lilly, which has asked for a ban on other parties making copies of its tirzepatide-based ...
Despite falling hard since last summer, shares of Novo Nordisk have more than doubled the market's overall performance. The ...
Novo Nordisk is intervening in the lawsuit filed by a drug compounders trade group against the FDA over the agency’s decision ...
While the Super Bowl may not always be the ideal spot for pharma, cultural events like the Oscars can offer a more ...
A federal court in Texas has rejected a request by producers of compounded drugs to extend their ability to manufacture ...
Despite comments made by a Novo Nordisk official this week, the company confirmed to BioSpace that it has no additional ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback